BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Machado-Joseph Disease

Below is an extended Machado-Joseph Disease research listing. Click here to return to the Machado-Joseph Disease main in depth entry.

Recent Publications on Machado-Joseph Disease:

Analysis of segregation patterns in Machado-Joseph disease pedigrees.
Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3...
Direct Link
9th August, 2008
Center of Research in Natural Resources (CIRN) and Department of Biology,
Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
Machado-Joseph disease (MJD) is a fatal, dominant neurodegenerative...
Direct Link
8th August, 2008
Center for Neurosciences and Cell Biology, University of Coimbra, Coimbra,
[The advances in research on phosphorylation of polyglutamine disease.] 7th August, 2008
Department of Neurology, Xiangya Hospital, Central South University,
PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner. 1st August, 2008
Laboratory of Molecular Neuropathology, Hefei National Laboratory for
Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation.
In the present study, we prepared a SCA3 animal model by generating...
Direct Link
30th July, 2008
Department of Anesthesiology, Chang Gung Memorial Hospital, Kwei-San,
Movement-related cortical potentials in patients with Machado-Joseph disease.
OBJECTIVE: Movement-related cortical potentials (MRCP; nomenclature of...
Direct Link
17th July, 2008
Neuroscience Laboratory, Department of Neurology, China Medical University
Homozygosity enhances severity in spinocerebellar ataxia type 3.
Spinocerebellar ataxia type 3, or Machado-Joseph disease, is an autosomal...
Direct Link
11th July, 2008
Genetic Unit, Sarah Network of Rehabilitation Hospitals, Brasilia, DF,
Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal).
Machado-Joseph disease (MJD) is caused by an expansion of a triplet repeat...
Direct Link
18th June, 2008
Department of Biology/CIRN, University of the Azores, Rua Mae de Deus,
New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).
PURPOSE OF REVIEW: This review summarizes recent neuropathological...
Direct Link
14th June, 2008
Institute for Clinical Neuroanatomy, J. W. Goethe-University, D-60590
cDNA cloning and tissue expression analyses of the encoding regions for three novel porcine genes- MJD1, CDC42 and NECD.
The cDNAs for Machado-Joseph disease protein 1 homolog (MJD1), cell...
Direct Link
13th June, 2008
Key Laboratory of Animal Nutrition and Feed of Yunnan Province, Yunnan
Fatigue and daytime somnolence in Machado Joseph Disease (spinocerebellar ataxia type 3).
Objective Machado-Joseph disease (MJD), also known as spinocerebellar...
Direct Link
3rd June, 2008
Cognitive and social cognitive functioning in spinocerebellar ataxia : a preliminary characterization.
INTRODUCTION : The spinocerebellar ataxias (SCAs), are rare...
Direct Link
29th May, 2008
Institute of Cognitive Neuroscience, 17 Queen Square, London, WC1N 3AR,
Muscle excitability abnormalities in Machado-Joseph disease.
OBJECTIVES: To estimate the frequency of and to characterize muscle...
Direct Link
22nd May, 2008
Department of Neurology, University of Campinas, Campinas, Sao Paulo,
Axonal Dysfunction in the Deep White Matter in Machado-Joseph Disease.
We evaluated spectroscopy findings at the deep white matter in...
Direct Link
17th May, 2008
Neuroimaging Laboratory, Universidade Estadual de Campinas-UNICAMP,
A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3).
Spinocerebellar ataxias (SCAs) are characterized by a heterogeneous set of...
Direct Link
8th May, 2008
Medical Genetics Service, Hospital de Clinicas de Porto Alegre, Porto
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional